Search
forLearn
5 / 801 resultslearn AHAs
learn benzoic acid
learn TeraBond™ (Actera)
learn threonine
Research
5 / 1000+ results
research 27604 Response to baricitinib in the treatment of patients with early and late onset alopecia areata in the phase 2 portion of BRAVE-AA1 randomized controlled trial
Baricitinib was effective in treating both early and late onset alopecia areata.
research LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.
research 32237 Clinician and patient evaluation of improvement for eyebrow and eyelashes hair loss during baricitinib phase 3 trials BRAVE-AA1 and BRAVE-AA2
Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.
research How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach
The study investigates the effectiveness of baricitinib 4 mg in treating severe alopecia areata (AA) by analyzing the time required to achieve significant hair regrowth. In a post hoc analysis of the BRAVE-AA1/2 trials, patients were categorized based on baseline disease severity and episode duration. Results showed that in severe AA cases (SALT score 50–94), 70% with short duration and 61% with long duration achieved initial improvement (SALT30) by Week 24, with 75% and 65% reaching treatment success (SALT score ≤ 20) by Week 52. In very severe AA cases (SALT score 95–100), 42% with short duration and 25% with long duration achieved SALT30 by Week 24, leading to 58% and 43% achieving treatment success by Week 52. The findings suggest that treatment should continue for at least 1 year before determining failure, especially in very severe cases.
research Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib
Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.
Community Join
5 / 1000+ resultscommunity Brave soldier leading the army
User saw new hair growth after 2 months of treatment. Others shared similar experiences and joked about hair soldiers reclaiming lost territory.
community Eddie Bravo talking about hair loss on JRE
The conversation is about a 53-year-old man's struggle with hair loss and the various perspectives on balding. It also mentions the use of finasteride as a hair loss treatment.
community How to deal with feeling ugly while balding but not brave enough to shave
An 18-year-old is dealing with hair loss and considering minoxidil and finasteride. Suggestions include starting finasteride, saving for a hair transplant, embracing baldness, and focusing on self-improvement.
community 2.5 months topical minoxidil Progress
The conversation is about a user's hair regrowth after 2.5 months using topical minoxidil. Some suggest adding finasteride for long-term results, while others share their experiences with side effects or alternative treatments like dermarolling and dietary improvements.
community Trial for TDM-105795 update from research office
The trial for TDM-105795 has been completed, and it was in phase 2A. The discussion seeks input on the next phases, 2B or 3, based on safety and efficacy.